IBDEI0Y8 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16995,0)
 ;;=P9012^^109^1066^4^^^^1
 ;;^UTILITY(U,$J,358.3,16995,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16995,1,1,0)
 ;;=1^P9012
 ;;^UTILITY(U,$J,358.3,16995,1,3,0)
 ;;=3^Cryoprecipitate,Ea Unit
 ;;^UTILITY(U,$J,358.3,16996,0)
 ;;=P9016^^109^1066^18^^^^1
 ;;^UTILITY(U,$J,358.3,16996,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16996,1,1,0)
 ;;=1^P9016
 ;;^UTILITY(U,$J,358.3,16996,1,3,0)
 ;;=3^RBC Leukocytes Reduced
 ;;^UTILITY(U,$J,358.3,16997,0)
 ;;=P9017^^109^1066^6^^^^1
 ;;^UTILITY(U,$J,358.3,16997,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16997,1,1,0)
 ;;=1^P9017
 ;;^UTILITY(U,$J,358.3,16997,1,3,0)
 ;;=3^Plasma 1 Donor Frz w/in 8hrs
 ;;^UTILITY(U,$J,358.3,16998,0)
 ;;=P9019^^109^1066^10^^^^1
 ;;^UTILITY(U,$J,358.3,16998,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16998,1,1,0)
 ;;=1^P9019
 ;;^UTILITY(U,$J,358.3,16998,1,3,0)
 ;;=3^Platelets,Ea Unit
 ;;^UTILITY(U,$J,358.3,16999,0)
 ;;=P9021^^109^1066^20^^^^1
 ;;^UTILITY(U,$J,358.3,16999,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16999,1,1,0)
 ;;=1^P9021
 ;;^UTILITY(U,$J,358.3,16999,1,3,0)
 ;;=3^Red Blood Cells,Ea Unit
 ;;^UTILITY(U,$J,358.3,17000,0)
 ;;=P9022^^109^1066^21^^^^1
 ;;^UTILITY(U,$J,358.3,17000,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17000,1,1,0)
 ;;=1^P9022
 ;;^UTILITY(U,$J,358.3,17000,1,3,0)
 ;;=3^Washed Red Blood Cells,Ea Unit
 ;;^UTILITY(U,$J,358.3,17001,0)
 ;;=P9023^^109^1066^5^^^^1
 ;;^UTILITY(U,$J,358.3,17001,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17001,1,1,0)
 ;;=1^P9023
 ;;^UTILITY(U,$J,358.3,17001,1,3,0)
 ;;=3^Frozen Plasma,Pooled,SD
 ;;^UTILITY(U,$J,358.3,17002,0)
 ;;=P9034^^109^1066^12^^^^1
 ;;^UTILITY(U,$J,358.3,17002,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17002,1,1,0)
 ;;=1^P9034
 ;;^UTILITY(U,$J,358.3,17002,1,3,0)
 ;;=3^Platelets,Pheresis
 ;;^UTILITY(U,$J,358.3,17003,0)
 ;;=P9035^^109^1066^8^^^^1
 ;;^UTILITY(U,$J,358.3,17003,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17003,1,1,0)
 ;;=1^P9035
 ;;^UTILITY(U,$J,358.3,17003,1,3,0)
 ;;=3^Platelet Pheres Leuko Reduced
 ;;^UTILITY(U,$J,358.3,17004,0)
 ;;=P9036^^109^1066^9^^^^1
 ;;^UTILITY(U,$J,358.3,17004,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17004,1,1,0)
 ;;=1^P9036
 ;;^UTILITY(U,$J,358.3,17004,1,3,0)
 ;;=3^Platelet Pheres Leukoredu Irrad
 ;;^UTILITY(U,$J,358.3,17005,0)
 ;;=P9038^^109^1066^16^^^^1
 ;;^UTILITY(U,$J,358.3,17005,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17005,1,1,0)
 ;;=1^P9038
 ;;^UTILITY(U,$J,358.3,17005,1,3,0)
 ;;=3^RBC Irradiated
 ;;^UTILITY(U,$J,358.3,17006,0)
 ;;=P9039^^109^1066^15^^^^1
 ;;^UTILITY(U,$J,358.3,17006,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17006,1,1,0)
 ;;=1^P9039
 ;;^UTILITY(U,$J,358.3,17006,1,3,0)
 ;;=3^RBC Deglycerolized
 ;;^UTILITY(U,$J,358.3,17007,0)
 ;;=P9040^^109^1066^17^^^^1
 ;;^UTILITY(U,$J,358.3,17007,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17007,1,1,0)
 ;;=1^P9040
 ;;^UTILITY(U,$J,358.3,17007,1,3,0)
 ;;=3^RBC Leuko Reduced Irradiated
 ;;^UTILITY(U,$J,358.3,17008,0)
 ;;=P9044^^109^1066^3^^^^1
 ;;^UTILITY(U,$J,358.3,17008,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17008,1,1,0)
 ;;=1^P9044
 ;;^UTILITY(U,$J,358.3,17008,1,3,0)
 ;;=3^Cryoprecip Reduced Plasma
 ;;^UTILITY(U,$J,358.3,17009,0)
 ;;=P9051^^109^1066^1^^^^1
 ;;^UTILITY(U,$J,358.3,17009,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17009,1,1,0)
 ;;=1^P9051
 ;;^UTILITY(U,$J,358.3,17009,1,3,0)
 ;;=3^Blood,L/R,CMV-Neg
 ;;^UTILITY(U,$J,358.3,17010,0)
 ;;=P9052^^109^1066^11^^^^1
 ;;^UTILITY(U,$J,358.3,17010,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17010,1,1,0)
 ;;=1^P9052
 ;;^UTILITY(U,$J,358.3,17010,1,3,0)
 ;;=3^Platelets,HLA-M,L/R,Ea Unit
